The Preclinical Evidence: What Animal Models Show The animal data on BPC-157 is where things get interesting
Injections are best for: Severe deficiencies, pernicious anemia, significant malabsorption issues, and when rapid symptom relief is needed
BPC-157 (Body Protection Compound-157) is a 15-amino-acid peptide that operates through nitric oxide system modulation, growth factor upregulation (VEGF, FGF, EGF), and FAK-paxillin pathway activation
While preclinical data is promising, its important to recognize that neither peptide is FDA-approved for human therapeutic use, and most evidence is derived from animal or laboratory studies
Your body manufactures peptides, enabling a vast array of bodily functions
Available in 3mL and 10mL sizes with lot-coded traceability and tamper-evident packaging